We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,981.00 | 1,985.00 | 1,987.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 22.81 | 4.38B |
Date | Subject | Author | Discuss |
---|---|---|---|
07/7/2017 10:14 | Dipped toe in here. Upside at some point | richtea2517 | |
07/7/2017 10:05 | Looking to buy in, but honestly where is the bottom? Down nearly another 2% as I type, surprised this has dipped into 1300's | qruz | |
07/7/2017 09:12 | I am following it, but not adding. Graph looks bad and company is very quiet. It should issue an initial trading statement and update on Time scale for applying to FDA again. This may help the share price | karateboy | |
07/7/2017 08:28 | Anyone nibbling | richtea2517 | |
06/7/2017 09:01 | If get to around 13.20 I will buy any one know when the next trading statement is | mrthomas | |
05/7/2017 14:40 | Justice - I agree there is nothing from my eyes that warrant such a downfall in the SP, I estimated a few months ago it would go between 1600-1800 check my post history. They announced obviously the FDA delay will compromise future earnings and had to reduce their forecasts. I'm eager to enter here but it's down another 1% as I type.. | qruz | |
05/7/2017 14:15 | Well I ask again what major disaster has befallen the company to warrant a 50% fall in SP? | justiceforthemany | |
05/7/2017 12:46 | Justice. A lot of brokers have lowered their guidance, hence the continued sell off, from just so far this week (below).. I'd expect it to continue falling. WEDNESDAY BROKER ROUND-UP Hikma Pharmaceuticals: Jefferies reiterates Underweight with a target price of 1390p. TUESDAY BROKER ROUND-UP Hikma Pharmaceuticals: HSBC maintains Reduce with a target price of 1410p. Source from HL. | qruz | |
05/7/2017 12:39 | 4 YEAR LOWS HERE. You have to go back to late 2013-14 to see the share price at these levels. For no good reason either. Yet another shorter orchestrated fall. 5.31% Aside from the delayed approval of a product they never had (!) tell me what other major disaster has befallen this company? The arabs/CEO Darwazah may well take this back into private ownership. After all this was 2650p this time last year. | justiceforthemany | |
03/7/2017 16:48 | I wonder if drops is related to Oklohama Atorney General suing few Pharmas.... | karateboy | |
03/7/2017 16:14 | yep averaging down soon! | chc15 | |
29/6/2017 13:32 | I've added today, hope I'm not averaging down soon!.. | chc15 | |
29/6/2017 09:00 | I agree it's a good buy, I bought in the last dip before Xmas and sold at earnings for a good profit. I'm looking to re-enter here but it's free falling every day! | qruz | |
28/6/2017 22:49 | The fact the family own a big portion of the company and it is currently relatively cheap are two of the reasons I bought today ! | eastbourne1982 | |
28/6/2017 21:27 | The problem for take over is the family who started this company owns the majority shares and they won't sell their baby cheap. I am going to start buying if share price goes below £14. | karateboy | |
28/6/2017 18:04 | Bought in today at £14.79. For me this is now a takeover candidate, it's a quality business at a very depressed price, throw in the weak pound and it must be tempting for one of the big boys. This was only two years ago: hxxp://www.fiercepha | eastbourne1982 | |
28/6/2017 11:27 | gotta be a bounce here soon??? | chc15 | |
28/6/2017 09:24 | eps is declining this year. | pyemckay | |
28/6/2017 09:23 | Not sure when the next trading update is but if they can make the same profits as last year for this year the. may be worth buying but of course one would like to see a bottom here as it seems to be in freefall. The good thing is that it is based in dollars and also it's reasonably profitable and it's got a good cash flow but of course that's all dependent on top line revenue holding up Like to think as some stage it be a good buy just glad I sold when I did r | mrthomas | |
28/6/2017 02:04 | HSBA, JPM & Cantor | tudes100 | |
27/6/2017 19:51 | Who did downgrade the shares Sandeep...? | karateboy | |
27/6/2017 15:14 | Broker forecasts have put the boot in! We need some more info on future products and product approval. Latest RNS give no clue to future financial progress. Some more Director Buys would also show confidence! | fez77 | |
27/6/2017 14:04 | Hikma which has been trading below fair value for some time has now dipped to a new low on news that its CEO is leaving.This could be the final dip. News of a new appointment for the post will rocket the shares higher. I bought in as the up side potential seems like a good bet | ch1ck | |
27/6/2017 08:25 | Some meaty downgrades today | sandeep67 | |
26/6/2017 11:20 | Pointless news | qruz |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions